Belly Fat Is a Metabolic Issue — Not a Cosmetic One
There is a conversation happening in women's health right now that we need to expand and as an Accredited Nutritionist working in this space I feel we need to be talking about this instead!
It is not just about what the scales say. It is not about the next weight loss drug. It is about something far more fundamental — your metabolic health. And for women in midlife, understanding this is genuinely life-changing.
So let’s take a step back and talk about what is actually happening in your body?
Let's start with visceral fat — the fat that accumulates deep in your abdomen, wrapping around your liver, intestines and pancreas.[1]
This is not cosmetic fat. This is metabolically active tissue that behaves like a rogue endocrine organ. It secretes inflammatory chemicals — including interleukin-6, leptin and tumour necrosis factor-alpha — that drive chronic low-grade inflammation, raise your risk of insulin resistance, type 2 diabetes and cardiovascular disease.[2][3]
And here is what most women are not told: visceral fat increases significantly during perimenopause and menopause, even in women who have not changed their eating or exercise habits.[4][5]
This happens because oestrogen is a key regulator of where your body stores fat. When oestrogen declines, fat storage shifts from the hips and thighs — where it was relatively protective — to the deep abdominal cavity, where it carries far greater metabolic consequences.[6][5]
Every centimetre added to your waist in midlife is a metabolic signal — not a cosmetic one. A waist circumference above 88cm in women is associated with substantially increased cardiometabolic risk.[3]
The Gut Connection Nobody Is Talking About
Here is where it gets even more interesting.
Your gut bacteria are responsible for clearing and regulating oestrogen from your body through a system called the estrobolome — a collection of bacterial genes that encode enzymes involved in oestrogen metabolism.[7][8]
When your microbiome is balanced, oestrogen is properly metabolised and excreted. When your gut microbiome is disrupted — through stress, poor diet, antibiotics, alcohol — these enzymes become dysfunctional and oestrogen gets recirculated back into the bloodstream through enterohepatic circulation.[7][9]
The result? Excess recirculated oestrogen can contribute to heavy or irregular periods, breast tenderness, mood swings, PMS and weight gain — symptoms that look hormonal on the surface but have a gut health root.[8]
And there is more.
Approximately 90–95% of your body's serotonin is produced in the gut — not the brain. [10] A disrupted gut microbiome leads to reduced serotonin production, which directly impacts mood, sleep quality and anxiety levels.[11][12]
This means gut inflammation can create anxiety and depression that look like mental health conditions but are fundamentally gut-related. The gut–brain axis is not a theory — it is one of the most active and significant areas in current research.[12][13]
What Should We Actually Be Testing?
If we want to understand a woman's metabolic health — not just her weight — we need to look far beyond the scales. Here is the baseline testing that tells the real story:
Metabolic & Blood Sugar Markers
- Fasting insulin and fasting glucose (fasting insulin is often missed but is one of the earliest indicators of insulin resistance)[14]
- HbA1c
- Lipid profile including triglycerides, HDL, LDL
Inflammation Markers
- High-sensitivity CRP (hsCRP) — visceral fat is itself inflammatory and will elevate this marker[15]
- Liver function tests (ALT, AST) — non-alcoholic fatty liver is strongly associated with insulin resistance in perimenopausal women[15]
Nutrition Markers
- Active B12 and folate — not just standard B12, which can miss functional deficiency
Taking care of your gut health is not separate from taking care of your mental health. They are the same conversation.
- Full iron studies including ferritin, serum iron, TIBC and transferrin saturation[16]
- Zinc and copper
- Vitamin D — deficiency impairs insulin sensitivity and drives fat cell proliferation[15]
Body Composition — Not Just Weight
- DEXA body composition scan to assess muscle mass, fat mass and bone density
- Waist circumference measurement — this is more predictive of metabolic disease than BMI alone[17]
- GI symptom tracking
The Plate. The Lifestyle. The Foundation.
Before we talk about medication, we need to talk about the foundation.
A simple, balanced plate — built around protein, fibre, healthy fats and complex carbohydrates — is one of the most powerful tools available for:
Stabilising blood sugar and reducing insulin spikes • Supporting the gut microbiome and estrobolome
Reducing visceral fat and systemic inflammation
Protecting muscle mass through midlife and beyond
Combined with regular resistance training, quality sleep, stress management and nervous system regulation — these are not complementary extras. They are the primary intervention.
An Important Conversation About GLP-1 Medications
GLP-1 receptor agonists have undoubtedly transformed obesity treatment and weight management. For many individuals, they are providing life-changing outcomes and opening doors that years of dieting and lifestyle interventions alone have not.
But as their use continues to grow — particularly among midlife women — there is a critical question that deserves more attention:
Where is the nutrition support?
GLP-1 medications suppress appetite and slow gastric emptying.[18] This supports weight loss — but it also significantly reduces overall food intake. Without appropriate nutritional
The number on the scales tells you very little about your metabolic health. Muscle mass, visceral fat, fasting insulin and inflammation markers tell you everything. This supports weight loss — but it also significantly reduces overall food intake. Without appropriate nutritional guidance, many individuals may struggle to consume adequate protein, fibre, vitamins and minerals.[19][20]
Research shows that a relevant proportion of total weight loss under GLP-1 therapy can be attributed to loss of lean mass, including skeletal muscle — not just fat.[21] One literature review reported that up to 50% of weight loss from GLP-1 medications may not be from fat loss, but from a reduction in muscle mass and other lean tissue.[22]
This concern is amplified in perimenopausal and menopausal women, where declining oestrogen already accelerates sarcopenia (muscle loss) and where muscle mass preservation is critical to metabolic health, bone density and long-term independence.[23][21]
As nutritionists, we should be asking:
Are clients preserving lean muscle mass?
Are they meeting their nutrient requirements?
Are they supporting gut health?
Are they building sustainable habits for long-term success?
What happens when the medication is discontinued?
Weight loss is only one measure of health.
If we focus solely on reducing body weight without addressing nutritional adequacy and lifestyle foundations, we risk seeing a rise in nutrient deficiencies, loss of muscle mass, reduced metabolic resilience and poorer long-term health outcomes.[19][20]
From a public health perspective are we at risk of creating a nutrition epidemic while trying to solve an obesity epidemic?
The future of obesity care should not be medication or nutrition. It should be medication and nutrition.
GLP-1 medications are powerful tools. But tools work best when supported by education, behavioural change, resistance training, adequate protein intake and personalised nutrition care.
The Bottom Line - Your belly fat is a metabolic signal. Your mood is a gut signal. Your energy is a nutrition signal.
When we step back and look at the whole picture — testing what actually matters, nourishing what actually needs support, moving in ways that build strength, and understanding the profound connection between the gut, hormones, metabolism and mental health — that is where real transformation happens.
Not in a quick fix. Not in a number on the scales.
In a body that is genuinely well.
If you would like to explore your metabolic health in depth, ask your GP or healthcare provider for a full metabolic panel including fasting insulin, hsCRP, full iron studies, active B12, folate, vitamin D and a body composition assessment.
References
The Connection Between Menopause & Belly Fat | University Hospitals
https://www.uhhospitals.org/blog/articles/2023/08/the-connection-between-menopause-and-belly-fat
Weight Management Module for Perimenopausal Women: A Practical Guide for Gynecologists - PMC
[PDF] Understanding weight gain at menopause
https://www.imsociety.org/wp-content/uploads/2020/07/wmd-2012-white-pages-english.pdf
How to get rid of menopause belly: visceral fat, bloating, and blood s
Estrogen and Metabolism: Navigating Hormonal Transitions from Perimenopause to Postmenopause
Obesity and Menopause: Redefining Obesity – New Guidelines - PMC
Frontiers | Gut microbiota has the potential to improve health of menopausal women by regulating estrogen
https://www.frontiersin.org/journals/endocrinology/articles/10.3389/fendo.2025.1562332/full
Diet, the Gut Microbiome, and Estrogen Physiology: A Review in Menopausal Health and Interventions
https://pmc.ncbi.nlm.nih.gov/articles/PMC13074627Gut microbiota has the potential to improve health of menopausal women by regulating estrogen
The Gut-Brain Connection: How Gut Health Impacts Mental Well-being
https://mbpain.com.au/the-gut-brain-connection-how-gut-health-impacts-mental-well-being
Gut over Mind: Exploring the Powerful Gut–Brain Axis
Trust your gut: how the microbiome impacts mental health | NHMRC
https://www.nhmrc.gov.au/about-us/news-centre/trust-your-gut-how-microbiome-impacts-mental-health
Why nurturing the gut microbiota could resolve depression and anxiety
Essentials in Metabolic Health online course | AMHS
Metabolic Lab Testing | Lapeer & Rochester Hills, MI
Nutrient Deficiency Testing: Optimizing Your Metabolic Health Through – RnA ReSet
A Holistic Approach to Metabolic Health Assessment—Analysis of Bioimpedance, Blood, and Saliva Biochemistry in Population Studies—A Pilot Study - PMC https://pmc.ncbi.nlm.nih.gov/articles/PMC12471435
[PDF] Clinical Practice Recommendations regarding patients taking GLP-1 ...
https://www.anzca.edu.au/getContentAsset/0f35028e-e371-4220-a49a-ddee877051c8/80feb437-d24d-46b8- a858-4a2a28b9b970/Clinical-Practice-Recommendations-Periprocedural-GLP-1RA-use-Apr-2025.pdf
Nutritional deficiencies and muscle loss in adults with type 2 diabetes using GLP-1 receptor agonists: A retrospective observational study
https://pmc.ncbi.nlm.nih.gov/articles/PMC12205620Interactions Between Nutrition and GLP-1 Therapy: The Risk of Sarcopenia in Weight Management | Revista de Medicina Clinica
https://www.medicinaclinica.org/index.php/rmc/en/article/view/697Muscle loss and GLP-1R agonists use
Muscle Loss and GLP-1s: Why It Matters and How To Address It - Virtual and in-person musculoskeletal healthcare | Vori Healthhttps://www.vorihealth.com/resource/muscle-loss-and-glp-1s-why-it-matters-and-how-to-address-it
Weight Loss Diet for Women Over 40: 9 Science-Backed Approaches | Menovivre
https://menovivre.ae/insights/science-backed-weight-loss-diet-menopause